Article

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosis

2023-07-03

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background/Objectives</h4> Serum proteomic analysis of deeply-phenotyped samples, biological pathway modeling and network analysis were performed to elucidate the inflammatory and neurodegenerative processes of multiple sclerosis (MS) and identify sensitive biomarkers of MS disease activity (DA). <h4>Methods</h4> Over 1100 serum proteins were evaluated in >600 samples from three MS cohorts to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9d1778da-f95f-5f9c-91ca-05637cab51c5
DOI: 10.1101/2023.06.28.23291157

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisDOI 10.1101/2023.06.28.23291157Read

Molecular mechanisms associated with multiple sclerosis progression, severity and phenotypeSemantic proximity Read

Proteomics profiling reveals biomarkers for predicting diagnosis, disease activity and long-term disability outcome in multiple sclerosisSemantic proximity Read

Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosisSemantic proximity Read

Molecular markers in the CSF proteome differentiate neuroinflammatory diseasesSemantic proximity Read

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosisSemantic proximity Read

Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple SclerosisSemantic proximity Read

Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosisSemantic proximity Read

Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients.Semantic proximity Read

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisSemantic proximity Read

Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple SclerosisSemantic proximity Read

Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosisSemantic proximity Read

Plasma proteome in multiple sclerosis disease progressionSemantic proximity Read